Thanks Corporal, you write: 'mysterious unreported shorters, I wrote shorters. And they are reported: http://www.nasdaq.com/symbol/pphm/short-interest Shorting has been going on forever. Small biotechs are an easy target. And sure, clinical trials are costly. That's the game: Pay to play. AVID is a solution to dilution. Ronin seems to think so. IMO sunstar